Open Access Open Access  Restricted Access Subscription Access

Development of Stem-Loop Real-Time PCR Technique for miRNA-141 Expression Analysis in Nasopharyngeal Carcinoma


Affiliations
1 Faculty of Biotechnology, Department of Pharmaceutical and Medical Biotechnology, Ho Chi Minh City Open University, Ward Co Giang, District 1, HCMC, Ho Chi Minh City, Viet Nam
 

Background: The deregulation of miRNA-141 (miR-141) has been reported to be involved in development and progression of many various types of human cancers. Previously, it has been demonstrated that miR-141 served as the oncogenic role in nasopharyngeal carcinoma in different countries. However, in Vietnam, to our knowledge, there are limit study of the types of evaluation of miR-141 expression. Objective: For the aims to find out the novel diagnosis strategies and promising therapies for many human based on the expression of miRNA, we the stem-loop qRT-PCR method described here is to detect mature miRNA-141 in a fast, specific, accurate, and reliable manner. Methods: StL-miR-141, known as stem-loop RT primer is applied for Reversed transcriptase assay, followed by Real-time PCR assay using StL-F, STL-R primer and SYBR-Green. Results: Experimentally, this method was applied in detection of miR-141 in Vietnamese NPC biopsy samples, as the results, 5 of six NPC were positive to miR-141 expression. Moreover, the electrophoresis analysis was performed to evaluate the Specificity. The assay has shown high specific for miR-141 detection. Conclusion: We successfully designed the stem-loop RT primer, StL-F, STL-R primer, might be used as a rapid, simple method for the detectionwith a wider scope to apply this method onto the Vietnamese population.

Keywords

miRNAs, miR-141, Stem-Loop RT PCR.
User
Notifications
Font Size

  • GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
  • Mahdavifar N, Ghoncheh M, Mohammadian-Hafshejani A, Khosravi B, Salehiniya H. Epidemiology and inequality in the incidence and mortality of nasopharynx cancer in Asia. Osong Public Health Res. Perspect. 2016; 7(6):360-72. https://doi.org/10.1016/j.phrp.2016.11.002. PMid: 28053841, PMCid: PMC5194228.
  • Epstein JB, Jones CK. Presenting signs and symptoms of nasopharyngeal carcinoma. Oral Surg. Oral. Med. Oral. Pathol. 1993; 75(1):32-36. https://doi.org/10.1016/00304220(93)90402-P.
  • Hao SP, Tsang NM, Chang KP, Ueng SH. Molecular diagnosis of nasopharyngeal carcinoma: Detecting LMP-1 and EBNA by nasopharyngeal swab. Otolaryngol Head Neck Surg. 2004; 131(5):651-54. https://doi.org/10.1016/j.otohns.2004.04.013. PMid: 15523443.
  • Liu Y, Zhao R, Wang H, Luo Y, Wang X, Niu W, et al. miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma. Cell Death Dis. 2016; 7:e2156. https://doi.org/10.1038/cddis.2016.64. PMid: 27010857, PMCid: PMC4823963.
  • Lee RC, Feinbaum RL, Ambros V. The C. elegansheterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993; 75(5):843-54. https://doi.org/10.1016/0092-8674(93)90529-Y.
  • Ha M, Kim VN. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell. Biol. 2014; 15(8):509-24. https://doi.org/10.1038/nrm3838. PMid: 25027649.
  • Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. https://doi.org/10.1016/S0092-8674(04)00045-5.
  • Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat. Rev. Cancer. 2006; 6(11):857-66. https://doi.org/10.1038/nrc1997. PMid: 17060945.
  • Faraoni I, Antonetti FR, Cardone J, Bonmassar E. miR-155 gene: A typical multifunctional microRNA. Biochim. Biophys. Acta. Biochim. Biophys. Acta. 2009; 1792(6):497-505. https://doi.org/10.1016/j.bbadis.2009.02.013. PMid: 19268705.
  • Macfarlane LA, Murphy PR. Micro RNA: Biogenesis, function and role in cancer. Curr. Genomics. 2010; 11(7):537-61. https://doi.org/10.2174/138920210793175895. PMid: 21532838, PMCid: PMC3048316.
  • Du ZM, Hu LF, Wang HY, Yan LX, Zeng YX, Shao JY, et al. Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and down regulates a negative prognostic marker JMJD1A. PLoS One. 2011; 6:e19137. https://doi.org/10.1371/journal.pone.0019137. PMid: 21541331, PMCid: PMC3082546.
  • Lovat F, Valeri N, Croce CM. MicroRNAs in the pathogenesis of cancer. Semin. Oncol. 2011; 38(6):724-33. https://doi.org/10.1053/j.seminoncol.2011.08.006. PMid: 22082758.
  • Amin M, Lam AK. Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management. Exp. Mol. Pathol. 2015; 98(3):411-18. https://doi.org/10.1016/j.yexmp.2015.03.002. PMid: 25746664.
  • Lee KT, Tan JK, Lam AK, Gan SY. MicroRNAs serving as potential biomarkers and therapeutic targets in nasopharyngeal carcinoma: A critical review. Crit. Rev. Oncol. Hematol. 2016; 103:1-9. https://doi.org/10.1016/j.critrevonc.2016.04.006. PMid:27179594.
  • Lao DT, Truong KP, Le HAT.miRNA-141 as the Biomarker for Human Cancers. JPRHC. 2018; 10:42-49. https://doi.org/10.18311/ajprhc/2018/21486.
  • Li G, Huang M, Cai Y, Ke Y, Yang Y, Sun X. miR 141 inhibits glioma vasculogenic mimicry by controlling EphA2 expression. Mol. Med. Rep. 2018(2); 18:1395-1404. https://doi.org/10.3892/ mmr.2018.9108.
  • Lin L, Liang H, Wang Y, Yin X, Hu Y, Huang J, et al. microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells. BMC cancer. 2014; 14:879. https://doi.org/10.1186/1471-2407-14-879. PMid: 25425543, PMCid: PMC4289273.
  • Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell. 2005; 122:6-7. https://doi.org/10.1016/j.cell.2005.06.036. PMid: 16009126.
  • Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, et al. Real-time quantification of microRNAs by stemloop RT-PCR. Nucleic Acids Res. 2005; 33(20):e179. https://doi.org/10.1093/nar/gni178. PMid: 16314309, PMCid: PMC1292995.

Abstract Views: 302

PDF Views: 237




  • Development of Stem-Loop Real-Time PCR Technique for miRNA-141 Expression Analysis in Nasopharyngeal Carcinoma

Abstract Views: 302  |  PDF Views: 237

Authors

Thuan Duc Lao
Faculty of Biotechnology, Department of Pharmaceutical and Medical Biotechnology, Ho Chi Minh City Open University, Ward Co Giang, District 1, HCMC, Ho Chi Minh City, Viet Nam
Thuy Ai Huyen Le
Faculty of Biotechnology, Department of Pharmaceutical and Medical Biotechnology, Ho Chi Minh City Open University, Ward Co Giang, District 1, HCMC, Ho Chi Minh City, Viet Nam

Abstract


Background: The deregulation of miRNA-141 (miR-141) has been reported to be involved in development and progression of many various types of human cancers. Previously, it has been demonstrated that miR-141 served as the oncogenic role in nasopharyngeal carcinoma in different countries. However, in Vietnam, to our knowledge, there are limit study of the types of evaluation of miR-141 expression. Objective: For the aims to find out the novel diagnosis strategies and promising therapies for many human based on the expression of miRNA, we the stem-loop qRT-PCR method described here is to detect mature miRNA-141 in a fast, specific, accurate, and reliable manner. Methods: StL-miR-141, known as stem-loop RT primer is applied for Reversed transcriptase assay, followed by Real-time PCR assay using StL-F, STL-R primer and SYBR-Green. Results: Experimentally, this method was applied in detection of miR-141 in Vietnamese NPC biopsy samples, as the results, 5 of six NPC were positive to miR-141 expression. Moreover, the electrophoresis analysis was performed to evaluate the Specificity. The assay has shown high specific for miR-141 detection. Conclusion: We successfully designed the stem-loop RT primer, StL-F, STL-R primer, might be used as a rapid, simple method for the detectionwith a wider scope to apply this method onto the Vietnamese population.

Keywords


miRNAs, miR-141, Stem-Loop RT PCR.

References





DOI: https://doi.org/10.18311/ajprhc%2F2019%2F24990